- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
166 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Albert-Ludwigs-University Freiburg, Germany, Dissertation, 2019
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:01 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- April 2019
Other Objects (12)
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma